Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rohde

Showing results (41-50 of 161) with videos related to

Pageof 17
Sort By:
Anticancer Research|September 2, 1999
Age related changes of free and total prostate specific antigen in serumJ M Wolff, H Borchers, D Rohde, et al.
International Journal of Oncology|June 4, 1998
The efficacy of 2',2'-difluorodeoxycytidine (gemcitabine) combined with interferon in human renal cell carcinoma cell linesD Rohde, H K Hayn, J Blatter, et al.
Urological Research|January 1, 1997
Local expression of cytokines in rat bladder carcinoma tissue after intravesical treatment with Nocardia rubra cell wall skeleton and bacille-Calmette-GuerinD Rohde, G Gastl, S Biesterfeld, et al.
International Journal of Oncology|April 30, 2011
Interferon-alpha and gemcitabine (2',2'-difluorodeoxycytidine) in adult and pediatric renal tumorsD Rohde, M Goertz, H Hayn, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1985
A new peritoneovenous shunt catheterE Guzman, B D Wigness, T D Rohde, et al.
Medical Progress Through Technology|November 30, 1979
The implantable infusion pump: a new concept in drug deliveryP J Blackshear, T D Rohde, F Prosl, et al.
Oncology Reports|October 14, 1998
Treatment of renal cancer patients with gemcitabine (2',2'-difluorodeoxycytidine) and interferons: antitumor activity and toxicityD Rohde, D Thiemann, J Wildberger, et al.
Urological Research|October 6, 1998
Induction of drug-resistant bladder carcinoma cells in vitro: impact on polychemotherapy with cisplatin, methotrexate and vinblastine (CMV)D Rohde, B Brehmer, T Kapp, et al.
Urological Research|October 6, 1998
7-N-(2-([2-(gamma-L-glutamylamino)-ethyl]-dithio)-ethyl)-mitomycin C (KW-2149) is more active than mitomycin C on chemonaive and drug-resistant urothelial carcinoma cellsD Rohde, G Raffenberg, S Kaviani, et al.
Atherosclerosis|January 1, 1977
The effect of continuous heparin infusion for one year on serum cholesterol and triglyceride concentrations in the dogP J Blackshear, T D Rohde, R L Varco, et al.
Pageof 17

Showing results (41-50 of 161) with videos related to

Sort By:
Pageof 17
Anticancer Research|September 2, 1999
Age related changes of free and total prostate specific antigen in serumJ M Wolff, H Borchers, D Rohde, et al.
International Journal of Oncology|June 4, 1998
The efficacy of 2',2'-difluorodeoxycytidine (gemcitabine) combined with interferon in human renal cell carcinoma cell linesD Rohde, H K Hayn, J Blatter, et al.
Urological Research|January 1, 1997
Local expression of cytokines in rat bladder carcinoma tissue after intravesical treatment with Nocardia rubra cell wall skeleton and bacille-Calmette-GuerinD Rohde, G Gastl, S Biesterfeld, et al.
International Journal of Oncology|April 30, 2011
Interferon-alpha and gemcitabine (2',2'-difluorodeoxycytidine) in adult and pediatric renal tumorsD Rohde, M Goertz, H Hayn, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1985
A new peritoneovenous shunt catheterE Guzman, B D Wigness, T D Rohde, et al.
Medical Progress Through Technology|November 30, 1979
The implantable infusion pump: a new concept in drug deliveryP J Blackshear, T D Rohde, F Prosl, et al.
Oncology Reports|October 14, 1998
Treatment of renal cancer patients with gemcitabine (2',2'-difluorodeoxycytidine) and interferons: antitumor activity and toxicityD Rohde, D Thiemann, J Wildberger, et al.
Urological Research|October 6, 1998
Induction of drug-resistant bladder carcinoma cells in vitro: impact on polychemotherapy with cisplatin, methotrexate and vinblastine (CMV)D Rohde, B Brehmer, T Kapp, et al.
Urological Research|October 6, 1998
7-N-(2-([2-(gamma-L-glutamylamino)-ethyl]-dithio)-ethyl)-mitomycin C (KW-2149) is more active than mitomycin C on chemonaive and drug-resistant urothelial carcinoma cellsD Rohde, G Raffenberg, S Kaviani, et al.
Atherosclerosis|January 1, 1977
The effect of continuous heparin infusion for one year on serum cholesterol and triglyceride concentrations in the dogP J Blackshear, T D Rohde, R L Varco, et al.
Pageof 17